Covetrus announces new organizational structure in Europe


This will help execute the company's 3-year strategy with a new Northern European leadership team while offering a reset for the German and UK businesses.

Covetrus has announced a new organizational structure within Northern and Central Europe to implement the company’s 3-year strategy, deliver operational efficiencies, and improve the ability of the company’s combined commercial teams to service customers and offer a reset for the German and UK businesses.

According to a company release, Covetrus hired András Bolcskei as its first president of International earlier in 2021. Bolcskei was charged with uniting all commercial teams outside of North America, and this announcement accelerates that plan. Critical changes include the development of a new International leadership team and a collaborative focus within the UK and German businesses, plus an immediate and strong reaction to recent pressures within those 2 areas.

Covetrus Germany will also transfer its DACH headquarter from Hamburg to Düsseldorf effective on April 1, 2022. Under the leadership of Andreas Tschuor, DECBHM, Dip.EDSRHM, MBA, this location will create the DACH hub while restrengthening its commercial capabilities, customer service and competitiveness within the German market. Plus, the proximity of Düsseldorf to 2 other Covetrus regions—Belgium and the Netherlands—will foster increased efficiencies and operational excellence within those regions’ commercial teams.

Covetus will close its Hamburg office on March 31, 2022, and employment contracts linked to Hamburg will be discontinued. Employees will have the choice to continue employment with unaffected conditions in the new Düsseldorf office.

What’s more, reflective of the model adopted in the US earlier this year, the UK commercial and the Global Technology Solutions (GTS) teams and the UK & Europe sales teams will unite under 1 commercial leadership led by Loic Jegou, country manager and VP, Northern Europe. This will be effective on January 1, 2022.

Jegou joined Covetrus in November 2021 with 18 years of experience in the animal health pharmaceutical business at Pfizer and MSD Animal Health. The UK business will enhance service to UK-based customers through the prioritization of the company’s “One Face to Customer” approach. Additionally, Australia and New Zealand are adopting the same go-to-market strategy, and the GTS sales team within the APAC region will report directly to Simon Hellams, VP, APAC.

“These moves position Covetrus to win for our European customers and win for our global business,” said Ben Wolin, President & CEO. “I have absolute confidence in our ability to drive our strategy, win back our position within the German and U.K. markets, drive greater outcomes for our customers and the animals they care for…and drive success for all our teams and stakeholders.”


Covetrus announces new structure, focus and strength within Europe. News release. Covetrus. December 21, 2021. Accessed December 22, 2021.

Related Videos
© 2023 MJH Life Sciences

All rights reserved.